The second highly expressed transcript is Kmt2c (lysine methyltransferase 2C), which is a tumour suppressor mutated or deleted in the peripheral T-cell lymphoma (Watatani et al., 2019) and myelodysplastic syndrome (MDS) (Chen et al., 2021). This evidence concerns the gene KMT2C and neoplasm.